FIELD: medical science.
SUBSTANCE: invention refers to medicine, namely to obstetrics and gynaecology, and can be used for the prediction of benign ovarian tumour development in postmenopausal females. Blood serum CA 125, vitamin D, SHBG, IGF1, FSH, oestradiol, zinc are determined in postmenopausal women. A predicted risk of developing benign ovarian tumours (p) is calculated. If p is equal to 0.55 or more, a high risk of benign ovarian tumours. If p is less than 0.55, a low risk of benign ovarian tumours.
EFFECT: method provides more accurate prediction of developing benign ovarian tumours in postmenopausal females by using the predictive model based on the medical history and laboratory values.
1 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RISK OF MALIGNANT GROWTHS IN FEMALE GENITAL ORGANS AND MAMMARY GLANDS | 2014 |
|
RU2578459C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF A SUBOPTIMALE RESPONSE TO CONTROLLED OVARIAN STIMULATION IN IVF/ICSI PROGRAMS | 2021 |
|
RU2774145C1 |
| METHOD FOR PREDICTION OF MENSTRUAL RECOVERY IN ADOLESCENT GIRLS WITH NORMOGONADOTROPIC OLIGOMENORRHEA | 2020 |
|
RU2740848C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT NEOPLASMS OF OVARIES | 2018 |
|
RU2686180C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING TYPE 2 PSORIASIS IN POSTMENOPAUSAL WOMEN | 2018 |
|
RU2684287C1 |
| METHOD OF DETERMINING RISK OF RECURRENCE OF ENDOMETRIOID OVARIAN CYSTS AFTER SURGICAL TREATMENT | 2023 |
|
RU2811890C1 |
| METHOD FOR LOW BONE MINERAL DENSITY SCREENING IN FEMALES SUFFERING FROM SECONDARY AMENORRHEA | 2014 |
|
RU2548822C1 |
| METHOD FOR PREDICTING CLINICAL EFFECTIVENESS OF CLIMACTERIC SYNDROME MELATONIN IN FEMALES IN PERIMENOPAUSAL AND POSTMENOPAUSAL WOMEN | 2019 |
|
RU2723764C1 |
| METHOD FOR PREDICTING THE POTENTIAL MALIGNITY OF OVARIAN TUMOR IN WOMEN OF REPRODUCTIVE AGE | 2019 |
|
RU2713795C1 |
| DIAGNOSTIC TECHNIQUE FOR ADOLESCENT'S REPRODUCTIVE DISORDERS ACCOMPANYING CHRONIC RENAL PATHOLOGY | 2013 |
|
RU2536288C1 |
